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BACKGROUND
Endoscopic ultrasound-guided pancreatic FNA has become
increasingly used in the diagnosis of pancreatic lesions. A
common diagnostic dilemma occurs with the presence of
suspected gastrointestinal epithelial contamination (GIC). Gastric
contamination is more problematic due to its similar appearance
to low-grade mucinous lesions. B72.3 showed promise in the
differentiation between benign and malignant ductal epithelium
in a baseline study of direct smears obtained from surgical
specimens (Nawgiri, 2007). Immunohistochemical staining for
CEA distinguished non-malignant cyst lining of intraductal
papillary mucinous neoplasm (IPMN) from contaminating
duodenal and gastric epithelium in a tissue microarray analysis
(Pitman, 2009). The goal of the present study is to determine
whether B72.3 and CEA can identify both duodenal and
gastric contamination in cell blocks of clinically proven cases
of pancreatic ductal carcinoma, IPMN, and mucinous cystic
neoplasm (MCN).

Representative photomicrographs illustrating the expression of CEA and B72.3 in gastrointestinal epithelium
and pancreatic lesions. CEA expression is limited to pancreatic neoplasms, while B72.3 expression is seen in
both neoplastic and benign contaminating epithelium (immunostains, original magnification x 400).

DESIGN
Cell blocks of pancreatic FNAs from 19 ductal adenocarcinomas,
8 IPMNs, 5 MCNs, and 22 cases containing GIC (7 gastric, 15
duodenal) were obtained. The material aspirated for the cell
block had been immediately placed in Sacomanno fixative
(containing ethanol, methanol, isopropyl alcohol and carbowax)
and fixed in 10% formalin following centrifugation.
The slides were stained with antibody to CEA (Dako) and B72.3
(Santa Cruz Biotechnology).

RESULT
CEA was positive in 89% of adenocarcinomas and 92% of mucinous lesions. It was never expressed in gastric contamination,
and positive in 2/15 (13%) duodenal contaminants. B72.3 was
positive in 95% of adenocarcinomas and 85% of mucinous
lesions. It was positive in 2/7 (28%) gastric and 7/15 (47%)
duodenal contaminants.

DISCUSSION
Transgastric FNAs are generally used for lesions in the body and
tail, while a transduodenal approaches are better suited to sample
lesions in the head and uncinate. While knowing the FNA
approach is important in the evaluation of suspected GIC, this
remains one piece of clinical information to be used in conjunction
with cytologic findings. Gastric mucosa exhibits monolayered,
glandular-like formations with round-oval bland nuclei and no
brush border. Duodenal mucosa appears as strips of columnar
epithelium with bland nuclei, luminal brush borders, and many
interspersed goblet cells.

In contrast to previous work, our preliminary results indicate
B72.3 expression cannot be reliably used to identify GIC.
Although B72.3 was consistently expressed in tumor, expression
was also found in >25% of GIC cases. A lack of CEA expression,
however, was able to identify both gastric and duodenal
contamination. Importantly, no cases of gastric contamination
showed CEA expression, and 13% of duodenal contamination
were positive. Our preliminary findings indicate gastric
contamination, which may appear cytologically identical to a
low-grade mucinous lesion, can be distinguished by a lack of
CEA expression.
The staining characteristics of B72.3 in our study are similar to prior
work that utilized a cytobrush to obtain material from Whipple
resections. In each study, goblet cells showed a diffusely granular
pattern, benign epithelial cells stained in a punctate perinuclear
fashion, and PDA showed strong cytoplasmic staining. The
previous studies used both air-dried and ethanol-fixed smears.
Our results show similar B72.3 staining with Sacomanno fixative
followed by centrifugation and fixation in 10% formalin. With
regards to GIC staining, our study found one case of gastric
contamination showing positive expression of apical mucin in
foveolar cells. This finding had been previously been described
by Nagle et al. Furthermore, duodenal contamination also
demonstrated expression limited to apical mucin in 4/7 (57%)
cases of B72.3 expression, and 2/2 (100%) cases of CEA
expression. As apical positivity was only noted in GIC, B72.3 or
CEA expression limited to apical cytoplasm should be
interpreted as negative staining and supportive of GIC.

CONCLUSION
In contrast to previous work, our preliminary results indicate B72.3
expression cannot be reliably used to identify GIC. A lack of CEA
expression, however, may be used to identify both gastric and
duodenal contamination. This represents an important diagnostic
aid in the evaluation of suspected low-grade mucinous lesions.

